Literature DB >> 11072218

Cervical cancer mortality in young women in Europe: patterns and trends.

F Levi1, F Lucchini, E Negri, S Franceschi, C la Vecchia.   

Abstract

On the basis of overall national death certification data, it is not possible to analyse mortality from cervical cancer in Europe, since 20-65% of deaths from uterine cancer in largest countries are still certified as uterus, unspecified. We analysed, therefore, age-standardised death certification rates from uterine cancer between 1960 and 1998 in women aged 20-44 years, since most deaths from uterine cancer below the age of 45 years arise from the cervix. In all Western European countries, except Ireland, substantial declines in cervical cancer mortality in younger women were observed, although the falls were larger and earlier for some Nordic countries. The trends were irregular in the UK, with earlier declines between 1960 and 1970, followed by a rise between 1970 and 1985, and a subsequent fall. In Ireland, mortality from uterine cancer at age 20 to 44 years has been rising since the early 1980s, to reach 3.4/100000 in 1995-1996. In Eastern Europe, some fall in mortality was observed in Hungary and Poland, while trends were upwards in Romania since 1980, and in Bulgaria. In all these countries, moreover, absolute rates remained appreciably higher than in most of Western Europe, and in the late 1990s there was over a 10-fold variation between the highest rates in Romania (10.6/100000 women aged 20-44 years) and the lowest ones in Finland (0.5/100000) or Sweden (0.9/100000). Within the European Union, the variation was over 6-fold, the highest rates being registered in Ireland (3. 4/100000) and Portugal (3.2/100000). The declines registered in cervical cancer mortality in young women were largely due to screening, and the persisting variations in mortality across Europe underline the importance of the adoption of organised screening programmes, with specific urgency in Eastern Europe.

Entities:  

Mesh:

Year:  2000        PMID: 11072218     DOI: 10.1016/s0959-8049(00)00346-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

1.  Inequalities in health in Europe.

Authors:  F Levi; F Lucchini; S Franceschi; E Negri; C La Vecchia
Journal:  BMJ       Date:  2001-03-31

2.  Epidemiological aspects of cancer screening in Germany.

Authors:  Nikolaus Becker
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

3.  Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.

Authors:  Jeffrey N Roberts; Rhonda C Kines; Hormuzd A Katki; Douglas R Lowy; John T Schiller
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

4.  Effect of pay-for-performance on cervical cancer screening participation in France.

Authors:  Panayotis Constantinou; Jonathan Sicsic; Carine Franc
Journal:  Int J Health Econ Manag       Date:  2016-12-22

5.  Expression of CDC42 in cervical squamous cell carcinoma and its correlation with clinicopathologic characteristics.

Authors:  Ding Ma; Yuan Cheng; Youyi Zhang; Yanli Guo; Zijian Li; Geng Li
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

Review 6.  Vaccines for cervical cancer.

Authors:  C M Lowndes
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

7.  Potential for improvement in cancer management: reducing mortality in the European Union.

Authors:  Carlo La Vecchia; Matteo Rota; Matteo Malvezzi; Eva Negri
Journal:  Oncologist       Date:  2015-04-17

Review 8.  [Humoral and cellular immune response in HPV vaccination].

Authors:  E Glastetter; A M Kaufmann
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

9.  Evidence for cervical cancer mortality with screening program in Taiwan, 1981-2010: age-period-cohort model.

Authors:  Shih-Yung Su; Jing-Yang Huang; Chien-Chang Ho; Yung-Po Liaw
Journal:  BMC Public Health       Date:  2013-01-08       Impact factor: 3.295

10.  Cervical cancer and pap smear awareness and utilization of pap smear test among Federal civil servants in North Central Nigeria.

Authors:  Hyacinth I Hyacinth; Oluwatoyosi A Adekeye; Joy N Ibeh; Tolulope Osoba
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.